Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India faces contaminated blood scandal

This article was originally published in Clinica

Executive Summary

India's Food and Drug Administration is investigating what threatens to be its biggest blood scandal since the introduction of compulsory HIV screening in 1989. The agency has withdrawn the licence of the Red Cross blood bank in Bombay following a complaint that it supplied several hospitals with HIV-contaminated blood between February 1992 and July 1994. ELISA equipment at the Bombay facility was out of action for at least 18 months, reports the BMJ.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT093072

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel